Please login to the form below
Wilmington Healthcare makes new senior appointment
Shelley who has worked for Wilmington Healthcare brands since graduating from university 17 years ago, will be overseeing a number of key accounts and ensuring that the specialist teams meet their objectives.
Shelley’s most recent post at Wilmington Healthcare was Business Development Director, responsible for all aspects of the sales cycle from identifying new opportunities to negotiating and closing deals.
Prior to that, Shelley was a sales consultant for Wilmington Healthcare’s NHiS Insight team, which provides business intelligence and insight solutions to the pharma industry.
Other posts that Shelley has held for Wilmington Healthcare companies include Business Development Manager and Assistant Research Manager for Binley’s, which provides healthcare data and intelligence to pharma.
Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Shelley has enjoyed a long and successful career with Wilmington Healthcare’s brands. I am very pleased to promote her to the role of account director. I know that she will continue to build on the strong relationships she has with her clients and be an extremely valuable asset to our expanding business.”
Ends
Company Details
Wilmington Healthcare
01268 495600
Address:
Beechwood House
2-3 Commercial Way
Christy Close
Southfields
Basildon
SS15 6EF
United Kingdom
Latest content on this profile
- UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW
- Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this latest quick-read briefing, Oli Hudson, Content Director at Wilmington Healthcare, lifts the veil on what place is, how it works and why it matters.
Wilmington Healthcare
- MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE
- With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is it responding to this challenge, and what can industry do to support it? Oli Hudson, Content Director at Wilmington Healthcare, explains what’s changing and how industry should respond.
Wilmington Healthcare
- ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS
- With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes and why they matter for pharma and med-tech companies.
Wilmington Healthcare
- HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW
- Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to the NHS and its prescribing behaviours during the peak of the pandemic. Oli Hudson summarises five of the key findings:
Wilmington Healthcare
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.
Wilmington Healthcare
- Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed
Wilmington Healthcare
